Cite
Jia R, Liu N, Cai G, et al. Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Front Oncol. 2021;11:618793doi: 10.3389/fonc.2021.618793.
Jia, R., Liu, N., Cai, G., Zhang, Y., Xiao, H., Zhou, L., Ji, Q., Zhao, L., Zeng, P., Liu, H., Huo, J., Yue, X., Zhang, Y., Wu, C., Sun, X., Feng, Y., Liu, H., Liu, H., Han, Z., Lai, Y., Zhang, Y., Han, G., Gong, H., Wang, Y., & Li, Q. (2021). Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Frontiers in oncology, 11618793. https://doi.org/10.3389/fonc.2021.618793
Jia, Ru, et al. "Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." Frontiers in oncology vol. 11 (2021): 618793. doi: https://doi.org/10.3389/fonc.2021.618793
Jia R, Liu N, Cai G, Zhang Y, Xiao H, Zhou L, Ji Q, Zhao L, Zeng P, Liu H, Huo J, Yue X, Zhang Y, Wu C, Sun X, Feng Y, Liu H, Liu H, Han Z, Lai Y, Zhang Y, Han G, Gong H, Wang Y, Li Q. Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Front Oncol. 2021 Mar 03;11:618793. doi: 10.3389/fonc.2021.618793. eCollection 2021. PMID: 33747930; PMCID: PMC7968418.
Copy
Download .nbib